Wesley Justino Magnabosco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wesley Justino Magnabosco has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Roberto Dias Machado
Departamento de Urologia, Hospital do Câncer de Barretos, Barretos, SP, Brasil
6 shared publicationsEliney Ferreira Faria
Departamento de Urologia, Hospital do Câncer de Barretos, Barretos, SP, Brasil
5 shared publicationsMarcos Tobias-Machado
Faculdade de Medicina do ABC, Brasil
4 shared publications- Leonardo Oliveira Reis
UroScience and Department of Surgery (Urology), School of Medical Sciences, University of Campinas, Unicamp, and Pontifical Catholic University of Campinas, PUC-Campinas, Campinas, São Paulo, Brazil
3 shared publications - Lucas Nogueira
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
3 shared publications - Rodolfo Borges dos Reis
Department of Surgery and Anatomy, Urology Division Ribeirao Preto School of Medicine, University of Sao Paulo Ribeirao Preto Sao Paulo Brazil
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 53
Latissimus dorsi myocutaneous flap: a good option for chest wall defect closure in locally advanced breast cancer
Introduction: Locally advanced breast cancer (LABC) often requires extensive surgical resection, resulting in large chest wall defects that necessitate flap reconstruction. In this context, the latissimus dorsi myocutaneous flap (LDMF) is a widely used reconstructive option; however, its association with local disease control remains unclear. Methods: This retrospective study included patients who underwent mastectomy followed by LDMF reconstruction for chest wall defect closure between 2010 and 2020. Data were analyzed descriptively. Actuarial survival was estimated using the Kaplan-Meier method, and comparisons between groups were performed using the log-rank test. Results: A total of 15 patients were included, with low rates of major postoperative complications. Cases of wound dehiscence and flap necrosis were successfully managed with debridement and resuturing. Mean recurrence-free survival was 13.3 months, while the actuarial survival rates were 46.7%, 26.7%, 17.8%, 8.9% and 8.9% at 12, 24, 36, 48 and 60 months respectively. Patients who achieved complete resection (R0) demonstrated improved overall survival compared with those who underwent incomplete resections (R1/R2). Conclusion: The LDMF proved to be a safe and effective option for chest wall defect closure in patients with LABC, with improved overall survival associated with complete (R0) resection.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 53
Open AccessLatissimus dorsi myocutaneous flap: a good option for chest wall defect closure in locally advanced breast cancer
Introduction: Locally advanced breast cancer (LABC) often requires extensive surgical resection, resulting in large chest wall defects that necessitate flap reconstruction. In this context, the latissimus dorsi myocutaneous flap (LDMF) is a widely used reconstructive option; however, its association with local disease control remains unclear. Methods: This retrospective study included patients who underwent mastectomy followed by LDMF reconstruction for chest wall defect closure between 2010 and 2020. Data were analyzed descriptively. Actuarial survival was estimated using the Kaplan-Meier method, and comparisons between groups were performed using the log-rank test. Results: A total of 15 patients were included, with low rates of major postoperative complications. Cases of wound dehiscence and flap necrosis were successfully managed with debridement and resuturing. Mean recurrence-free survival was 13.3 months, while the actuarial survival rates were 46.7%, 26.7%, 17.8%, 8.9% and 8.9% at 12, 24, 36, 48 and 60 months respectively. Patients who achieved complete resection (R0) demonstrated improved overall survival compared with those who underwent incomplete resections (R1/R2). Conclusion: The LDMF proved to be a safe and effective option for chest wall defect closure in patients with LABC, with improved overall survival associated with complete (R0) resection.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 53
Latíssimo do dorso: uma boa opção para o fechamento do defeito torácico em câncer de mama localmente avançado
RESUMO Introdução: O carcinoma mamário localmente avançado (CMLA) muitas vezes requer amplas ressecções cirúrgicas, necessitando de retalhos para o fechamento do defeito torácico. Nesse contexto, o retalho miocutâneo do latíssimo do dorso (RM-LD) é uma opção amplamente utilizada; entretanto, é desconhecida a sua associação com o controle local da doença. Metodologia: Estudo retrospectivo que incluiu pacientes submetidas à mastectomia com RM-LD para fechamento do defeito torácico, no período de 2010 a 2020. Os dados foram apresentados de maneira descritiva. A sobrevida atuarial foi estimada pelo método de Kaplan-Meier, e a comparação entre os grupos foi realizada pelo teste de log-rank. Resultados: Foram incluídas 15 pacientes, com baixas taxas de complicações; os casos de deiscência e necrose foram resolvidos por debridamento e ressutura. A sobrevida média livre de recorrência foi de 13,3 meses, e a sobrevida atuarial global foi de 46,7%, 26,7%, 17,8%, 8,9% e 8,9% aos 12, 24, 36, 48 e 60 meses, respectivamente. Pacientes com ressecção completa (R0) apresentaram melhor sobrevida global em comparação com aquelas com ressecções incompletas (R1/R2). Conclusão: O RM-LD mostrou-se seguro no fechamento do defeito torácico em pacientes com CMLA, com melhor sobrevida global quando obtida ressecção completa (R0).
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 53
Open AccessLatíssimo do dorso: uma boa opção para o fechamento do defeito torácico em câncer de mama localmente avançado
RESUMO Introdução: O carcinoma mamário localmente avançado (CMLA) muitas vezes requer amplas ressecções cirúrgicas, necessitando de retalhos para o fechamento do defeito torácico. Nesse contexto, o retalho miocutâneo do latíssimo do dorso (RM-LD) é uma opção amplamente utilizada; entretanto, é desconhecida a sua associação com o controle local da doença. Metodologia: Estudo retrospectivo que incluiu pacientes submetidas à mastectomia com RM-LD para fechamento do defeito torácico, no período de 2010 a 2020. Os dados foram apresentados de maneira descritiva. A sobrevida atuarial foi estimada pelo método de Kaplan-Meier, e a comparação entre os grupos foi realizada pelo teste de log-rank. Resultados: Foram incluídas 15 pacientes, com baixas taxas de complicações; os casos de deiscência e necrose foram resolvidos por debridamento e ressutura. A sobrevida média livre de recorrência foi de 13,3 meses, e a sobrevida atuarial global foi de 46,7%, 26,7%, 17,8%, 8,9% e 8,9% aos 12, 24, 36, 48 e 60 meses, respectivamente. Pacientes com ressecção completa (R0) apresentaram melhor sobrevida global em comparação com aquelas com ressecções incompletas (R1/R2). Conclusão: O RM-LD mostrou-se seguro no fechamento do defeito torácico em pacientes com CMLA, com melhor sobrevida global quando obtida ressecção completa (R0).
- Open Access
- 1 October 2018
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 44 (5) , 1036-1041
Neovagina construction and continent cutaneous urinary reservoir using a previous orthotopic ileal neobladder
Standard radical cystectomy (RC) in women involves removal of the distal ureters, bladder, proximal urethra, uterus, ovaries, and adjacent vagina. Furthermore, pelvic organ-preserving RC to treat selected women has become an accepted technique and may confer better postoperative sexual and urinary functions than standard RC, avoiding complications such as incontinence, prolapse, neobladder-vaginal fistula (NVF), and sexual dysfunction, without compromising oncological outcome.
- 1 October 2018
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 44 (5) , 1036-1041
Open AccessNeovagina construction and continent cutaneous urinary reservoir using a previous orthotopic ileal neobladder
Standard radical cystectomy (RC) in women involves removal of the distal ureters, bladder, proximal urethra, uterus, ovaries, and adjacent vagina. Furthermore, pelvic organ-preserving RC to treat selected women has become an accepted technique and may confer better postoperative sexual and urinary functions than standard RC, avoiding complications such as incontinence, prolapse, neobladder-vaginal fistula (NVF), and sexual dysfunction, without compromising oncological outcome.
- Open Access
- 1 June 2018
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 44 (3) , 483-490
Synchronous abdominal tumors: is combined laparoscopic surgery in a single approach a safe option?
Keywords: Laparoscopy; Neoplasms; Neoplasms, Multiple Primary
- 1 June 2018
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 44 (3) , 483-490
Open AccessSynchronous abdominal tumors: is combined laparoscopic surgery in a single approach a safe option?
Keywords: Laparoscopy; Neoplasms; Neoplasms, Multiple Primary
- 1 February 2018
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 28 (2) , 168-173
Laparoscopic Retroperitoneal Lymph Node Dissection as a Safe Procedure for Postchemotherapy Residual Mass in Testicular Cancer
Background: To evaluate the feasibility, clinical and perioperative outcomes of laparoscopic retroperitoneal lymph node dissection (L-RPLND) in the management of patients with germ cell tumors (GCT) and residual post-chemotherapy mass. Methods: We report our experience of 25 patients treated with L-RPLND between 2008 and 2015. All 25 patients were diagnosed with GCT by primary pathological evaluation of the specimens after orchiectomy. All patients received cisplatin-based chemotherapy. The technique consisted of L-RPLND excision of the residual mass using unilateral template dissection. We assessed perioperative data and histological findings. Results: Surgery was successfully completed in 24 (96%) patients, 1 patient required an open surgery due to intense adhesions of the mass to the inferior vena cava. Mean operation time was 213 minutes. Mean blood loss was 260 mL. Postoperative complications were upper limb osteomuscular pain in 2 patients and chylous ascites in 1 patient. Mean postoperative hospital stay was 2 days. The median residual mass diameter was 3.3 cm (range 1.1–6.6 cm). Histopathological findings were necrotic tissue in 9 patients, teratoma in 9 patients, viable tumor in 6 patients, and Castleman disease in 1 patient. The median follow-up was 30 months. Normal antegrade ejaculation was preserved in all patients. Conclusions: Laparoscopic postchemotherapy RPLND is a feasible, safe, and highly oncologically efficient procedure, which has the benefits of minimally invasive surgery.
- 1 February 2018
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 28 (2) , 168-173
Laparoscopic Retroperitoneal Lymph Node Dissection as a Safe Procedure for Postchemotherapy Residual Mass in Testicular Cancer
Background: To evaluate the feasibility, clinical and perioperative outcomes of laparoscopic retroperitoneal lymph node dissection (L-RPLND) in the management of patients with germ cell tumors (GCT) and residual post-chemotherapy mass. Methods: We report our experience of 25 patients treated with L-RPLND between 2008 and 2015. All 25 patients were diagnosed with GCT by primary pathological evaluation of the specimens after orchiectomy. All patients received cisplatin-based chemotherapy. The technique consisted of L-RPLND excision of the residual mass using unilateral template dissection. We assessed perioperative data and histological findings. Results: Surgery was successfully completed in 24 (96%) patients, 1 patient required an open surgery due to intense adhesions of the mass to the inferior vena cava. Mean operation time was 213 minutes. Mean blood loss was 260 mL. Postoperative complications were upper limb osteomuscular pain in 2 patients and chylous ascites in 1 patient. Mean postoperative hospital stay was 2 days. The median residual mass diameter was 3.3 cm (range 1.1–6.6 cm). Histopathological findings were necrotic tissue in 9 patients, teratoma in 9 patients, viable tumor in 6 patients, and Castleman disease in 1 patient. The median follow-up was 30 months. Normal antegrade ejaculation was preserved in all patients. Conclusions: Laparoscopic postchemotherapy RPLND is a feasible, safe, and highly oncologically efficient procedure, which has the benefits of minimally invasive surgery.
- Open Access
- 1 January 2018
- Published by Society of Physical Therapy Science in Journal of Physical Therapy Science
- Vol. 30 (6) , 825-831
Pelvic floor muscle training and electrical stimulation as rehabilitation after radical prostatectomy: a randomized controlled trial
[Purpose] To investigate the effect of electrical stimulation and pelvic floor muscle training on muscle strength, urinary incontinence and erectile function in men with prostate cancer treated by radical prostatectomy. [Subjects and Methods] One hundred twenty-three males were randomized into 3 groups 1 month after RP: (G1, n=40) control; (G2, n=41) guideline: patients were instructed to perform three types of home exercises to strengthen the pelvic floor and (G3, n=42) electrical stimulation: patients in this group were also instructed to perform exercises as group G2, and also received anal electro-stimulation therapy, twice a week for 7 weeks. The primary outcome assessment was based on the measurement of the recovery of pelvic floor muscle strength between groups. Secondary outcomes were: 1 hour Pad Test, ICIQ-SF, IIEF-5 and IPSS. Data were obtained preoperatively and at 1, 3 and 6 months after surgery. [Results] There was no significant difference in the demographic data among groups. Greater urinary leakage and pelvic floor muscle weakness in the first month compared to pre treatment improved after 3 and 6 months postoperative, without difference among groups. [Conclusion] The muscle strength recovery occurs independently of the therapy employed. Pelvic floor exercises or electrical stimulation also did not have an impact on the recovery of urinary continence and erectile function in our study.
- 1 January 2018
- Published by Society of Physical Therapy Science in Journal of Physical Therapy Science
- Vol. 30 (6) , 825-831
Open AccessPelvic floor muscle training and electrical stimulation as rehabilitation after radical prostatectomy: a randomized controlled trial
[Purpose] To investigate the effect of electrical stimulation and pelvic floor muscle training on muscle strength, urinary incontinence and erectile function in men with prostate cancer treated by radical prostatectomy. [Subjects and Methods] One hundred twenty-three males were randomized into 3 groups 1 month after RP: (G1, n=40) control; (G2, n=41) guideline: patients were instructed to perform three types of home exercises to strengthen the pelvic floor and (G3, n=42) electrical stimulation: patients in this group were also instructed to perform exercises as group G2, and also received anal electro-stimulation therapy, twice a week for 7 weeks. The primary outcome assessment was based on the measurement of the recovery of pelvic floor muscle strength between groups. Secondary outcomes were: 1 hour Pad Test, ICIQ-SF, IIEF-5 and IPSS. Data were obtained preoperatively and at 1, 3 and 6 months after surgery. [Results] There was no significant difference in the demographic data among groups. Greater urinary leakage and pelvic floor muscle weakness in the first month compared to pre treatment improved after 3 and 6 months postoperative, without difference among groups. [Conclusion] The muscle strength recovery occurs independently of the therapy employed. Pelvic floor exercises or electrical stimulation also did not have an impact on the recovery of urinary continence and erectile function in our study.
- Open Access
- 2 July 2013
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 7 (7-8) , 499-501
Primary proximal urethral adenocarcinoma: Case report and brief review
Primary urethral cancer in females is rare. It has a poor prognosis. The published data on this topic are limited, composed mostly of small case series. This paper presents a case of an advanced adenocarcinoma of the urethra, intestinal type, treated with anterior exenteration.
- 2 July 2013
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 7 (7-8) , 499-501
Open AccessPrimary proximal urethral adenocarcinoma: Case report and brief review
Primary urethral cancer in females is rare. It has a poor prognosis. The published data on this topic are limited, composed mostly of small case series. This paper presents a case of an advanced adenocarcinoma of the urethra, intestinal type, treated with anterior exenteration.
- Open Access
- 1 June 2013
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 39 (3) , 328-334
Association between Literacy, Compliance with Prostate Cancer Screening, and Cancer Aggressiveness: Results from a Brazilian Screening Study
Key words: Prostatic Neoplasms; Health Literacy; Mass Screening; Diagnosis
- 1 June 2013
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 39 (3) , 328-334
Open AccessAssociation between Literacy, Compliance with Prostate Cancer Screening, and Cancer Aggressiveness: Results from a Brazilian Screening Study
Key words: Prostatic Neoplasms; Health Literacy; Mass Screening; Diagnosis
- Open Access
- 1 January 2013
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 28 (suppl 1) , 43-47
Cutaneous ureterostomy with definitive ureteral stent as urinary diversion option in unfit patients after radical cystectomy
PURPOSE: Simple diversions are underutilized, mostly for unfit, bedridden, and very self-limited patients requiring palliative surgical management due to life-threatening conditions. Experience with cutaneous ureterostomy (CU) as palliative urinary diversion option for unfit bladder cancer patients is reported. METHODS: We retrospectively reviewed clinical and operative parameters of 41 patients who underwent CU following RC in three specialized Cancer Centers from July/2005 to July/2010. Muscle-invasive disease (clinical Stage T2/worse), multifocal high-grade tumor, and carcinoma in situ refractory to intravesical immunotherapy were the main indications for RC. Double-J ureteral stents were used in all patients and replaced every 6 months indefinitly. Peri-operative morbidity and mortality were evaluated. RESULTS: Median age was 69 years (interquartile range - IQR 62, 76); 30 (73%) patients were men. Surgery in urgency setting was performed in 25 (61%) of patients, most due to severe bleeding associated with hemodynamic instability; 14 patients (34%) showed an American Society of Anesthesiologists score 4. Median operative time was 180 minutes (IQR 120, 180). Peri-operative complications occurred in 30 (73%) patients, most Clavien grade I and II (66.6 %). There was no per-operative death. Re-intervention was necessary in 7 (17%) patients. Overall survival was 24% after 9.4 months follow-up. CONCLUSIONS: CU with definitive ureteral stenting represents a simplified alternative for urinary diversion after palliative cystectomy in unfit patients. It can be performed quickly, with few early and late postoperative complications allowing RC in a group of patients otherwise limited to suboptimal alternatives. Future studies regarding the quality of life are warranted.
- 1 January 2013
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 28 (suppl 1) , 43-47
Open AccessCutaneous ureterostomy with definitive ureteral stent as urinary diversion option in unfit patients after radical cystectomy
PURPOSE: Simple diversions are underutilized, mostly for unfit, bedridden, and very self-limited patients requiring palliative surgical management due to life-threatening conditions. Experience with cutaneous ureterostomy (CU) as palliative urinary diversion option for unfit bladder cancer patients is reported. METHODS: We retrospectively reviewed clinical and operative parameters of 41 patients who underwent CU following RC in three specialized Cancer Centers from July/2005 to July/2010. Muscle-invasive disease (clinical Stage T2/worse), multifocal high-grade tumor, and carcinoma in situ refractory to intravesical immunotherapy were the main indications for RC. Double-J ureteral stents were used in all patients and replaced every 6 months indefinitly. Peri-operative morbidity and mortality were evaluated. RESULTS: Median age was 69 years (interquartile range - IQR 62, 76); 30 (73%) patients were men. Surgery in urgency setting was performed in 25 (61%) of patients, most due to severe bleeding associated with hemodynamic instability; 14 patients (34%) showed an American Society of Anesthesiologists score 4. Median operative time was 180 minutes (IQR 120, 180). Peri-operative complications occurred in 30 (73%) patients, most Clavien grade I and II (66.6 %). There was no per-operative death. Re-intervention was necessary in 7 (17%) patients. Overall survival was 24% after 9.4 months follow-up. CONCLUSIONS: CU with definitive ureteral stenting represents a simplified alternative for urinary diversion after palliative cystectomy in unfit patients. It can be performed quickly, with few early and late postoperative complications allowing RC in a group of patients otherwise limited to suboptimal alternatives. Future studies regarding the quality of life are warranted.
- 14 August 2012
- Published by Wiley in BJU International
- Vol. 110 (11b) , E653-E657
Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL
Study Type – Diagnostic (inception cohort) Level of Evidence 2b What's known on the subject? and What does the study add? In spite of its low specificity, PSA is the most widely used screening test for prostate cancer (PCa), and is considered the main cause of the stage migration recently observed. The ratio of free to total PSA (%fPSA) has been shown to increase PSA accuracy in cancer detection; however, few screening studies have systematically evaluated its role in cancer detection rates in men with PSA levels P = 0.02). Among those who underwent radical prostatectomy, pathological stage and the proportion of insignificant tumours were similar between men with PSA 2.5–3.9 ng/mL, normal DRE findings and %fPSA ≤15, and men with PSA ≥4.0 ng/mL. CONCLUSIONS: The use of %fPSA ≤15 as a biopsy indication in men with normal DRE and PSA 2.5–4.0 ng/mL in a PCa screening programme, increased cancer detection rates. Tumours in this subset of patients had similar pathological characteristics. Using %fPSA ≤15 to indicate biopsy in men with PSA 2.5–3.9 ng/mL is a useful adjunct to PCa screening.
- 14 August 2012
- Published by Wiley in BJU International
- Vol. 110 (11b) , E653-E657
Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL
Study Type – Diagnostic (inception cohort) Level of Evidence 2b What's known on the subject? and What does the study add? In spite of its low specificity, PSA is the most widely used screening test for prostate cancer (PCa), and is considered the main cause of the stage migration recently observed. The ratio of free to total PSA (%fPSA) has been shown to increase PSA accuracy in cancer detection; however, few screening studies have systematically evaluated its role in cancer detection rates in men with PSA levels P = 0.02). Among those who underwent radical prostatectomy, pathological stage and the proportion of insignificant tumours were similar between men with PSA 2.5–3.9 ng/mL, normal DRE findings and %fPSA ≤15, and men with PSA ≥4.0 ng/mL. CONCLUSIONS: The use of %fPSA ≤15 as a biopsy indication in men with normal DRE and PSA 2.5–4.0 ng/mL in a PCa screening programme, increased cancer detection rates. Tumours in this subset of patients had similar pathological characteristics. Using %fPSA ≤15 to indicate biopsy in men with PSA 2.5–3.9 ng/mL is a useful adjunct to PCa screening.